Verve Therapeutics Inc (NASDAQ:VERV) shares, rose in value, with the stock price down by -5.47% to the previous day’s close as strong demand from buyers drove the stock to $6.22.
Actively observing the price movement in the last trading, the stock closed the session at $6.58. Referring to stock’s 52-week performance, its high was $21.42, and the low was $6.42. On the whole, VERV has fluctuated by -51.37% over the past month.
Wall Street analysts also predicted that the company’s y-o-y revenues would reach 2.02M.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that VERV’s technical picture suggests that short-term indicators denote the stock is a 100% Sell on average. However, medium-term indicators have put the stock in the category of 100% Sell while long-term indicators on average have been pointing out that it is a 100% Sell.
The stock’s technical analysis shows that the PEG ratio is about 0, with the price of VERV currently trading nearly -26.47% and -47.70% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 21.97, while the 7-day volatility ratio is showing 6.91% which for the 30-day chart, stands at 7.43%. Furthermore, Verve Therapeutics Inc (VERV)’s beta value is 1.89, and its average true range (ATR) is 0.71.
A comparison of Verve Therapeutics Inc (VERV) with its peers suggests the former has fared considerably weaker in the market. VERV showed an intraday change of -5.47% in last session, and over the past year, it shrunk by -60.43%%.
Data on historical trading for Verve Therapeutics Inc (NASDAQ:VERV) indicates that the trading volumes over the past 3 months, they’ve averaged 1.29 million. According to company’s latest data on outstanding shares, there are 81.97 million shares outstanding.
Nearly 30.25% of Verve Therapeutics Inc’s shares belong to company insiders and institutional investors own 72.31% of the company’s shares. The stock has fallen by -55.38% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the VERV stock heading into the next quarter.
